Print

Ligand Pharmaceuticals Inc. (LGND) to Report Second Quarter Results on August 1st  
7/17/2013 6:17:14 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report second quarter 2013 financial results on Thursday, August 1, 2013. Ligand’s President and CEO, John Higgins, Executive Vice President and COO, Matt Foehr and Vice President of Finance and CFO, John Sharp will host the conference call.

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

//-->